Abstract
Transcatheter aortic valve implantation (TAVI) is an established treatment for inoperable patients or patients at high risk for surgery. Despite growing experience, issues remain associated with first-generation TAVI devices, including valve malpositioning, vascular complications, paravalvular regurgitation and conduction disorders. Several second-generation TAVI devices, aimed at addressing these issues, are CE marked or under evaluation for CE marking. The objective of this overview is to describe and illustrate the key design features of the second-generation devices that are entering contemporary clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
